Maravai LifeSciences
MRVI
MRVI
206 hedge funds and large institutions have $1.06B invested in Maravai LifeSciences in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 72 increasing their positions, 70 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
-4
Holders Change %
-1.9%
% of All Funds
3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
72
Reduced
70
Closed
43
Calls
$1.52M
Puts
$208K
Net Calls
+$1.31M
Net Calls Change
-$365K
Top Buyers
| 1 |
Jennison Associates
New York
|
+$29.8M |
| 2 |
BlackRock
New York
|
+$23.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.9M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$12.9M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$20.8M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14.7M |
| 3 |
GL
GTCR LLC
Chicago,
Illinois
|
-$11M |
| 4 |
D.E. Shaw & Co
New York
|
-$8.02M |
| 5 |
Morgan Stanley
New York
|
-$6.33M |
